Ledger.Open graph →
SEC Form D · Amendment · filed July 16, 2021

Ventyx Biosciences, Inc

Offering
$114.3M
Sold
$114.3M
Exemption
Rule 506(b)
Industry
Other
Location
ENCINITAS, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Jigar W. Choksey · Encinitas, CADirectorRaju W. Mohan · Encinitas, CAExec · DirectorChristopher W. Krueger · Encinitas, CAExecWilliam W. White · Encinitas, CADirectorRichard W. Gaster · Encinitas, CADirectorSomasundaram W. Subramaniam · Encinitas, CADirectorAaron W. Royston · Encinitas, CADirectorSheila W. Gujrathi · Encinitas, CADirectorMartin W. Auster · Encinitas, CAExecBrendan F. Mcintee · New York, NYExecJeff F. Nirenberg · New York, NYDirectorUstin Zarubin · CHATTANOOGA, TNDirectorRyan Pace · Scottsdale, AZDirectorJack Karavich · Glen Allen, VADirectorStephen Butz · San Jose, CAExecTimothy V. Woodward · Ypsilanti, MIDirectorJohn F. Prete · New York, NYExec · DirectorJose V. Nunez-Regueiro · Ypsilanti, MIDirectorColleen Calhoun · Cambridge, MAExecCarlos Araque · Cambridge, MADirectorWilliam Restrepo · Cambridge, MAExec · DirectorBruce E. Fuller · Portland, ORDirectorJoseph Mclean · San Ramon, CADirector1819 Partners, LLC · Memphis, TNDirectorJoseph D. Morrison · Memphis, TNDirectorAndrew D. Hursey · Memphis, TNDirectorJohn D. Brooks · Memphis, TNExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗